Kesimpta pregnancy safety study using real-world data
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at the safety of Kesimpta (a multiple sclerosis medication) during pregnancy. It compares outcomes for women who took Kesimpta or other MS drugs while pregnant to those who did not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were pregnant and the pregnancy ended in a live birth, miscarriage, stillbirth, ectopic pregnancy, or you had an abortion during the study period.
- You were between 18 and 49 years old at the start of your pregnancy.
- You were diagnosed with multiple sclerosis before your pregnancy started.
- Your medical records include information about MS medications you took for at least 12 months before becoming pregnant.
- You did not take any medicines known to cause birth defects during pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information about pregnancy outcomes in people with multiple sclerosis (MS) who have taken Kesimpta (ofatumumab) during pregnancy or shortly before it. It may help doctors better understand safety and developmental outcomes for babies.
This study follows pregnant people with multiple sclerosis (MS) who took Mayzent (siponimod) to understand safety for pregnancy outcomes. It compares them with other groups to see whether there are any differences in birth results.
This study compares how well two medicines, Kesimpta and Ocrevus, work for people with multiple sclerosis when used in real life. It looks at patient records to see which treatment might be more effective.
This trial looks at the safety of ozanimod taken during pregnancy for parents with multiple sclerosis and for their babies after birth. It may help doctors understand the risks and benefits of this medicine during early pregnancy.
This study tracks pregnant women with certain chronic health conditions (like multiple sclerosis, lupus, or rheumatoid arthritis) and healthy pregnant women as a comparison group. It aims to understand how these conditions and their treatments affect pregnancy, the baby, and breast milk.
This study looks at how certain multiple sclerosis medications (monoclonal antibodies) might affect the immune system of children whose mothers took them during pregnancy. It aims to understand if these treatments have any impact on the baby's developing immune system.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.